Skip to main content

CORRECTION article

Front. Oncol., 29 March 2022
Sec. Molecular and Cellular Oncology
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.819908

Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways

This article is a correction to:

  1. LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR-665/HOXB5 and MiR-873-5p/CADM1 Pathways

    1. Read original article
Jie Wang&#x;Jie Wang1†Pingping Shi*&#x;Pingping Shi2*†Huaixiang TengHuaixiang Teng3Lixiang LuLixiang Lu4Hailong GuoHailong Guo2Xiuqin WangXiuqin Wang2
  • 1Gynaecology Clinic, People’s Hospital of Rizhao, Rizhao, China
  • 2No. 2 Department of Gynaecology, People’s Hospital of Rizhao, Rizhao, China
  • 3Reproductive Medicine Center, Maternal and Child Health Hospital of Rizhao, Rizhao, China
  • 4No. 2 Department of Gynaecology, Baiqiuen Hospital of Rizhao, Rizhao, China

A Corrigendum on
LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR-665/HOXB5 and MiR-873-5p/CADM1 Pathways

by Wang J, Shi P, Teng H, Lu L, Guo H and Wang X (2021) Front. Oncol. 11:714652. doi: 10.3389/fonc.2021.714652

In the original article, Changjiang Lei was designated as one of the authors. Changjiang Lei has now been removed from the author list. The corrected Author Contributions Statement appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Author Contributions

PS and JW designed and conducted the experiments. HT, LL, HG, and XW analyzed the data. JW wrote the manuscript and PS revised the manuscript. All authors contributed to the article and approved the submitted version.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: endometrial cancer, long noncoding RNA, DC-STAMP domain-containing 1-antisense 1, microRNA-665, homeobox B5, microRNA-873-5p, cell adhesion molecule 1

Citation: Wang J, Shi P, Teng H, Lu L, Guo H and Wang X (2022) Corrigendum: LncRNA DCST1-AS1 Promotes Endometrial Cancer Progression by Modulating the MiR- 665/HOXB5 and MiR-873-5p/CADM1 Pathways. Front. Oncol. 12:819908. doi: 10.3389/fonc.2022.819908

Received: 22 November 2021; Accepted: 04 March 2022;
Published: 29 March 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Wang, Shi, Teng, Lu, Guo and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Pingping Shi, qwek152@163.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.